Augmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance

2 years ago

HITRUST risk-based certification validates Augmedix’s commitment to strong cybersecurity and key regulations to protect sensitive dataSAN FRANCISCO, Aug. 24, 2023…

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

2 years ago

BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that…

SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor

2 years ago

CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical…

EDAP Announces Second Quarter 2023 Financial Results

2 years ago

- Record second quarter and first half revenues of EUR 14.3 million (USD 15.5 million) and EUR 29.1 million (USD…

Philips integrates AI in cardiac ultrasound and across cardiac care at ESC 2023

2 years ago

A clinician with Compact Ultrasound 5500CV and patient Cardiovascular Workspace image and information management solution in use A patient wearing…

CancerVAX CEO Ryan Davies Discussed Cancer Immunotherapy with UCLA Physician-Scientist

2 years ago

Dr. Steven Jonas commented about his journey to becoming both a practicing cancer doctor and active cancer researcherLEHI, Utah, Aug.…

Mithra prices private placement to raise EUR 20 million in equity

2 years ago

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA…

Six-month interim report (Q2) 2023

2 years ago

ALK delivers 11% revenue growth with operating profit up 120% in Q2 (unaudited) ALK’s revenue grew by 11% in Q2…

Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023

2 years ago

PRESS RELEASE: 24 August 2023, 07:00 CEST BIOCARTIS ANNOUNCES 2023 HALF-YEAR RESULTS ON 26 SEPTEMBER 2023 Mechelen, Belgium, 24 August 2023 –…

BioSenic receives a Chinese patent with broad claims, protecting the combined use of metal ions and arsenic salts to treat a wide range of serious diseases

2 years ago

INSIDE INFORMATION Composition-of-matter patent covers the therapeutic use of arsenic salts and metal ions through various routes of administrationEnriched IP…